X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (39) 39
index medicus (38) 38
female (34) 34
male (32) 32
middle aged (29) 29
aged (24) 24
oncology (24) 24
adult (18) 18
cancer (18) 18
survival (15) 15
prognosis (13) 13
antineoplastic combined chemotherapy protocols - therapeutic use (12) 12
chemotherapy (12) 12
life sciences (12) 12
prospective studies (12) 12
treatment outcome (12) 12
analysis (11) 11
surgery (11) 11
care and treatment (10) 10
aged, 80 and over (9) 9
kaplan-meier estimate (9) 9
medical prognosis (9) 9
diagnosis (8) 8
oxaliplatin (8) 8
patients (8) 8
quality of life (8) 8
clinical trials (7) 7
disease-free survival (7) 7
graft rejection - immunology (7) 7
neoplasm staging (7) 7
abridged index medicus (6) 6
classification (6) 6
colorectal cancer (6) 6
fluorouracil (6) 6
metastasis (6) 6
multivariate analysis (6) 6
proportional hazards models (6) 6
research (6) 6
risk factors (6) 6
time factors (6) 6
transplantation (6) 6
cancer patients (5) 5
cardiac & cardiovascular systems (5) 5
chemotherapy, adjuvant (5) 5
cohort studies (5) 5
combination (5) 5
failure (5) 5
health aspects (5) 5
hla antigens - immunology (5) 5
injury (5) 5
kidney transplantation (5) 5
medicine, general & internal (5) 5
neoplasms. tumors. oncology. including cancer and carcinogens (5) 5
organoplatinum compounds - administration & dosage (5) 5
quality-of-life (5) 5
retrospective studies (5) 5
urology & nephrology (5) 5
1st-line treatment (4) 4
[sdv.can]life sciences [q-bio]/cancer (4) 4
age factors (4) 4
antibodies (4) 4
antibody-mediated rejection (4) 4
cancer therapies (4) 4
clinical trials, phase ii as topic (4) 4
colon cancer (4) 4
colonic neoplasms - drug therapy (4) 4
colonic neoplasms - pathology (4) 4
fluorouracil - administration & dosage (4) 4
follow-up studies (4) 4
france (4) 4
gemcitabine (4) 4
health-related quality of life (4) 4
human health and pathology (4) 4
leucovorin (4) 4
model (4) 4
open-label (4) 4
randomized controlled trials as topic (4) 4
risk (4) 4
studies (4) 4
study protocol (4) 4
survival rate (4) 4
therapy (4) 4
tissue donors (4) 4
transplant recipients (4) 4
usage (4) 4
[ sdv.can ] life sciences [q-bio]/cancer (3) 3
adults (3) 3
antigens (3) 3
bevacizumab (3) 3
bevacizumab - administration & dosage (3) 3
biopsy (3) 3
carcinoma (3) 3
cisplatin (3) 3
clinical medicine (3) 3
clinical research (3) 3
clinical-trials (3) 3
colorectal neoplasms - drug therapy (3) 3
colorectal neoplasms - pathology (3) 3
confidence intervals (3) 3
expression (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 15, pp. 1493 - 1505
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2013, Volume 369, Issue 13, pp. 1215 - 1226
Journal Article
BRITISH JOURNAL OF CANCER, ISSN 0007-0920, 08/2019, Volume 121, Issue 4, pp. 312 - 317
BACKGROUND: Adjuvant treatment for stage II colon cancer (CC) can be proposed to patients with high-risk disease. Recently, 2.35 ng/mL carcinoembryonic antigen... 
LEUCOVORIN | CARCINOEMBRYONIC ANTIGEN | ONCOLOGY | FLUOROURACIL | Antigens | Carcinoembryonic antigen | Oxaliplatin | Colon cancer | Risk groups | Colorectal cancer | Health risks | Risk | Colon | Survival | Cancer
Journal Article
Journal Article
The Lancet Oncology, ISSN 1470-2045, 08/2018, Volume 19, Issue 8, pp. 1094 - 1106
Journal Article
Journal Article